A sumoylation site in PML/RARA is essential for leukemic transformation

Cancer Cell

Volumn 7, Issue 2, 2005, Pages 143-153

  Zhu, Jun ^a,b   Zhou, Jun ^a,b   Peres, Laurent ^a   Riaucoux, Florence ^a   Honoré, Nicole ^a   Kogan, Scott ^c   De Thé, Hugues ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAXX PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DIMERIZATION; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN BINDING; SUMOYLATION SITE; TRANSCRIPTION TERMINATION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 13844269220     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.01.005     Document Type: Article

References (65)

1. R. Bernardi, S. Grisendi, and P.P. Pandolfi Modeling haematopoietic malignancies in the mouse and therapeutical implications Oncogene 21 2002 3445 3458
2. C. Boutell, A. Orr, and R.D. Everett PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0 J. Virol. 77 2003 8686 8694
3. D. Brown, S. Kogan, E. Lagasse, I. Weissman, M. Alcalay, P.G. Pelicci, S. Atwater, and J.M. Bishop A PML RAR alpha transgene initiates murine acute promyelocytic leukemia Proc. Natl. Acad. Sci. USA 94 1997 2551 2556
4. C.C. Chang, D.Y. Lin, H.I. Fang, R.H. Chen, and H.M. Shih Daxx mediates the SUMO-dependant transcriptional repression of Smad4 J. Biol. Chem. 2005 10.1074/jbc.M409161200
5. G.X. Cheng, X.H. Zhu, X.Q. Men, L. Wang, Q.H. Huang, X.L. Jin, S.M. Xiong, J. Zhu, W.M. Guo, and J.Q. Chen Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha Proc. Natl. Acad. Sci. USA 96 1999 6318 6323
6. S. Cote, D. Zhou, A. Bianchini, C. Nervi, R.E. Gallagher, and W.H. Miller Jr. Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia Blood 96 2000 3200 3208
7. M.-T. Daniel, M. Koken, O. Romagné, S. Barbey, A. Bazarbachi, M. Stadler, M.-C. Guillemin, L. Degos, C. Chomienne, and H. de Thé PML protein expression in hematopoietic and acute promyelocytic leukemia cells Blood 82 1993 1858 1867
8. H. de Thé, C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR Cell 66 1991 675 684
9. H. de Thé, M.d.M. Vivanco-Ruiz, P. Tiollais, H. Stunnenberg, and A. Dejean Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene Nature 343 1990 177 180
10. L. Di Croce, V.A. Raker, M. Corsaro, F. Fazi, M. Fanelli, M. Faretta, F. Fuks, F.L. Coco, T. Kouzarides, and C. Nervi Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor Science 295 2002 1079 1082
11. S. Dong, J. Zhu, A. Reid, P. Strutt, F. Guidez, H.J. Zhong, Z.Y. Wang, J. Licht, S. Waxman, and C. Chomienne Amino-terminal protein-protein interaction motif (POZ domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor a gene fusion protein Proc. Natl. Acad. Sci. USA 93 1996 3624 3629
12. C. Du, R.L. Redner, M.P. Cooke, and C. Lavau Overexpression of wild-type retinoic acid receptor alpha (RAR alpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RAR alpha-fusion genes Blood 94 1999 793 802
13. E. Duprez, G. Benoit, M. Flexor, J.R. Lillehaug, and M. Lanotte A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities Leukemia 14 2000 255 261
14. V. Gottifredi, and C. Prives P53 and PML: New partners in tumor suppression Trends Cell Biol. 11 2001 184 187
15. F. Grignani, P. Ferrucci, U. Testa, G. Talamo, M. Fagioli, M. Alcalay, A. Mencarelli, F. Grignani, C. Peschle, I. Nicoletti, and P. Pelicci The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells Cell 74 1993 423 431
16. F. Grignani, S. de Matteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F.F. Ferrara, and I. Zamir Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia Nature 391 1998 815 818
17. L.A. Hansen, D. Brown, V. Virador, T. Tanaka, F. Andreola, K. Strain, B. Dancheck, R. Riley, J.M. Arbeit, and L.M. De Luca A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis Cancer Res. 63 2003 5257 5265
18. L.-Z. He, C. Tribioli, R. Rivi, D. Peruzzi, P.G. Pelicci, V. Soares, G. Cattoretti, and P.P. Pandolfi Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice Proc. Natl. Acad. Sci. USA 94 1997 5302 5307
19. L.-Z. He, F. Guidez, C. Tribioli, D. Peruzzi, M. Ruthardt, A. Zelent, and P.P. Pandolfi Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL Nat. Genet. 18 1998 126 135
20. L.Z. He, T. Tolentino, P. Grayson, S. Zhong, R.P. Warrell Jr., R.A. Rifkind, P.A. Marks, V.M. Richon, and P.P. Pandolfi Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia J. Clin. Invest. 108 2001 1321 1330
21. A.D. Hollenbach, J.E. Sublett, C.J. McPherson, and G. Grosveld The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx EMBO J. 18 1999 3702 3711
22. A.M. Ishov, A.G. Sotnikov, D. Negorev, O.V. Vladimirova, N. Neff, T. Kamitani, E. Yeh, J. Strauss, and G. Maul PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1 J. Cell Biol. 147 1999 221 234
23. J.H. Jansen, A. Mahfoudi, S. Rambaud, C. Lavau, W. Wahli, and A. Dejean Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways Proc. Natl. Acad. Sci. USA 92 1995 7401 7405
24. D.E. Kamashev, D. Vitoux, and H. de Thé PML/RARA-RXR oligomers mediate retinoid- and rexinoid-/cAMP in APL cell differentiation J. Exp. Med. 199 2004 1 13
25. T. Kamitani, K. Kito, H.P. Nguyen, H. Wada, T. Fukuda-Kamitani, and E.T.H. Yeh Identification of three major sentrinization sites in PML J. Biol. Chem. 41 1998 26675 26682
26. S.I. Kang, W.J. Chang, S.G. Cho, and I.Y. Kim Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity J. Biol. Chem. 278 2003 51479 51483
27. P. Kastner, A. Perez, Y. Lutz, C. Rochette-Egly, M.-P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins EMBO J. 11 1992 629 642
28. P. Kastner, H.J. Lawrence, C. Waltzinger, N.B. Ghyselinck, P. Chambon, and S. Chan Positive and negative regulation of granulopoiesis by endogenous RARalpha Blood 97 2001 1314 1320
29. E. Kim, S.J. Park, and J.S. Um Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML Nucleic Acids Res. 31 2003 5356 5367
30. S.C. Kogan, D.E. Brown, D.B. Shultz, B.T. Truong, V. Lallemand- Breitenbach, M.C. Guillemin, E. Lagasse, I.L. Weissman, and J.M. Bishop BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia J. Exp. Med. 193 2001 531 544
31. S.C. Kogan, J.M. Ward, M.R. Anver, J.J. Berman, C. Brayton, R.D. Cardiff, J.S. Carter, S. de Coronado, J.R. Downing, and T.N. Fredrickson Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice Blood 100 2002 238 245
32. V. Lallemand-Breitenbach, M.C. Guillemin, A. Janin, M.T. Daniel, L. Degos, S. Kogan, M. Bishop, and H. de Thé Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia J. Exp. Med. 189 1999 1043 1052
33. V. Lallemand-Breitenbach, J. Zhu, F. Puvion, M. Koken, N. Honore, A. Doubeikovsky, E. Duprez, P.P. Pandolfi, E. Puvion, P. Freemont, and H. de Thé Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As(2)O(3)-induced PML or PML/retinoic acid receptor alpha degradation J. Exp. Med. 193 2001 1361 1372
34. F. Lehembre, S. Muller, P.P. Pandolfi, and A. Dejean Regulation of Pax3 transcriptional activity by SUMO-1-modified PML Oncogene 20 2001 1 9
35. J.-Y. Li, M.A. English, H.J. Ball, P.L. Yeyati, S. Waxman, and J.D. Licht Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein J. Biol. Chem. 272 1997 22447 22455
36. H. Li, C. Leo, J. Zhu, X. Wu, J. O'Neil, E.J. Park, and J.D. Chen Sequestration and inhibition of daxx-mediated transcriptional repression by PML Mol. Cell. Biol. 20 2000 1784 1796
37. R. Lin, and R. Evans Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers Mol. Cell 5 2000 821 830
38. R.J. Lin, L. Nagy, S. Inoue, W.L. Shao, W.H. Miller, and R.M. Evans Role of the histone deacetylase complex in acute promyelocytic leukaemia Nature 391 1998 811 814
39. D.Y. Lin, M.Z. Lai, D.K. Ann, and H.M. Shih Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential J. Biol. Chem. 278 2003 15958 15965
40. A. Melnick, and J.D. Licht Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 93 1999 3167 3215
41. J.S. Michaelson, and P. Leder RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX J. Cell Sci. 116 2003 345 352
42. J.S. Michaelson, D. Bader, F. Kuo, C. Kozak, and P. Leder Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development Genes Dev. 13 1999 1918 1923
43. S. Minucci, M. Maccarana, M. Cioce, P. De Luca, V. Gelmetti, S. Segalla, L. Di Croce, S. Giavara, C. Matteucci, and A. Gobbi Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation Mol. Cell 5 2000 811 820
44. R. Muromoto, K. Sugiyama, K. Takachi, S. Imoto, N. Sato, T. Yamamoto, K. Oritani, K. Shimoda, and T. Matsuda Physical and functional interactions between Daxx and DNA Methyltransferase 1-associated protein, DMAP1 J. Immunol. 172 2004 2985 2993
45. A. Perez, P. Kastner, S. Sethi, Y. Lutz, C. Reibel, and P. Chambon PML/RAR homodimers: Distinct binding properties and heteromeric interactions with RXR EMBO J. 12 1993 3171 3182
46. F. Piazza, C. Gurrieri, and P.P. Pandolfi The theory of APL Oncogene 20 2001 7216 7222
47. L.E. Purton, I.D. Bernstein, and S.J. Collins All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells Blood 95 2000 470 477
48. F. Quignon, F. de Bels, M. Koken, J. Feunteun, J.-C. Ameisen, and H. de Thé PML induces a caspase-independent cell death process Nat. Genet. 20 1998 259 265
49. T.H. Rabbitts Chromosomal translocations in human cancer Nature 372 1994 143 149
50. P. Salomoni, and P.P. Pandolfi The role of PML in tumor suppression Cell 108 2002 165 170
51. S. Segalla, L. Rinaldi, C. Kilstrup-Nielsen, G. Badaracco, S. Minucci, P.G. Pelicci, and N. Landsberger Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties Mol. Cell. Biol. 23 2003 8795 8808
52. W. Shao, L. Benedetti, W.W. Lamph, C. Nervi, and W.H.J. Miller A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation Blood 89 1997 4282 4289
53. M.A. Sukhai, X. Wu, Y. Xuan, T. Zhang, P.P. Reis, K. Dube, E.M. Rego, M. Bhaumik, D.J. Bailey, and R.A. Wells Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha Oncogene 23 2004 665 678
54. S. Vallian, J.A. Gäken, I.D. Trayner, E.B. Gingold, T. Kouzarides, K.-S. Chang, and F. Farzaneh Transcriptional repression by the promyelocytic leukemia protein, PML Exp. Cell Res. 237 1997 371 382
55. A. Verger, J. Perdomo, and M. Crossley Modification with SUMO. A role in transcriptional regulation EMBO Rep. 4 2003 137 142
56. Z.-G. Wang, D. Ruggero, S. Ronchetti, S. Zhong, M. Gaboli, R. Rivi, and P.P. Pandolfi PML is essential for multiple apoptotic pathways Nat. Genet. 20 1998 266 272
57. R.P. Warrell, L.-Z. He, V. Richon, E. Calleja, and P.P. Pandolfi Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase J. Natl. Cancer Inst. 90 1998 1621 1625
58. W.S. Wu, S. Vallian, E. Seto, W.M. Yang, D. Edmondson, S. Roth, and K.S. Chang The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases Mol. Cell. Biol. 21 2001 2259 2268
59. S. Zhong, S. Muller, S. Ronchetti, P.S. Freemont, A. Dejean, and P.P. Pandolfi Role of SUMO-1-modified PML in nuclear body formation Blood 95 2000 2748 2752
60. S. Zhong, P. Salomoni, S. Ronchetti, A. Guo, D. Ruggero, and P.P. Pandolfi Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis J. Exp. Med. 191 2000 631 639
61. D.C. Zhou, S.H. Kim, W. Ding, C. Schultz, R.P. Warrell Jr., and R.E. Gallagher Frequent mutations in the ligand-binding domain of PML-RAR alpha after multiple relapses of acute promyelocytic leukemia: Analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo Blood 99 2002 1356 1363
62. J. Zhu, M.H.M. Koken, F. Quignon, M.K. Chelbi-Alix, L. Degos, Z.Y. Wang, Z. Chen, and H. de Thé Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemia Proc. Natl. Acad. Sci. USA 94 1997 3978 3983
63. J. Zhu, M. Gianni, E. Kopf, N. Honore, M. Chelbi-Alix, M. Koken, F. Quignon, C. Rochette-Egly, and H. de Thé Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins Proc. Natl. Acad. Sci. USA 96 1999 14807 14812
64. J. Zhu, V. Lallemand-Breitenbach, and H. de Thé Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission Oncogene 20 2001 7257 7265
65. J. Zhu, Z. Chen, V. Lallemand-Breitenbach, and H. de Thé How acute promyelocytic leukemia revived arsenic Nat. Rev. Cancer 2 2002 705 713